2025 Event

World Drug Safety Congress EU

Date: October 7th-8th
Location: Amsterdam, The Netherlands

Booth #6

The World Drug Safety Congress Europe provides a platform for discussing advancements in AI, quality assurance, and signal management to improve drug safety processes. Our experts will present case studies on how outsourcing drug safety from protocol to patient helps improve patient safety while reducing cost and effort. Come and meet our team at the congress to network and discuss key safety processes.

Speaker session at Automation track, Day 1, October 7th, 17:25 – 17:45

How automation increases efficiency and accuracy of local PV monitoring and KPI tracking

Managing local affiliate pharmacovigilance services across different countries and regions presents significant challenges due to complex and unique regulatory requirements. Consistent performance and tracking of these activities is essential not only for regulatory compliance but also for monitoring key performance indicators (KPIs) and adherence to service level agreements (SLAs).

This presentation will explore a validated system that successfully automates the collection and reporting of local pharmacovigilance metrics and KPIs across over 100 countries. We will examine how streamlining these processes significantly improves consistency and accuracy while reducing administrative burden, enabling local pharmacovigilance specialists to focus on critical safety issues.

Presenter: Iain Barnden, PV Business Partner, Digital Innovation, Cencora

Connect with us at the booth #6

Iain Barnden

Business Partner, Pharmacovigilance

Cheryl James

Director, PV Services

José Miguel Rivas

Director, Pharmacovigilance

Nina Andersson

Manager, Business Development

Abdullah Yassin

Manager, Business Development

With team across North America, Europe, and Asia-Pacific region, we blend global reach with local expertise

3,000

Consultants worldwide

30+

Global markets covered

235+

Brands represented

Helping breakthroughs break through

At Cencora, we’re leading the way to a place where your life-changing therapies can soar to impossible heights. Together, let’s create healthier futures for more patients around the globe.

Learn more

Maximize patient safety and minimize risk throughout your product life cycle

Patient safety is a primary mandate of every health authority worldwide and we know that pharmacovigilance (PV) teams are facing growing operational challenges and resource constraints. That's why we offer local and global pharmacovigilance services to improve the success of product launches and post-market growth, while freeing up safety and clinical teams to focus on strategic priorities. Our customers gain a competitive edge with access to more than 1000 subject matter experts and native resources in over 150 countries.

Discover more

Join us for this on-demand webinar

How full pharmacovigilance outsourcing increases efficiency and accuracy

In the face of increasing market pressures and an uncertain global environment, biopharmaceutical companies are seeking new avenues to help optimize efficiencies and cost structures. Leading organizations are finding success by shifting from functional outsourcing for pharmacovigilance areas such as case processing to a complete end-to-end pharmacovigilance outsourcing model.

Access the recording

Meet with us at World Drug Safety Congress EU

Interested in learning more? We're here to answer questions and to support your Pharmacovigilance needs. Schedule time to meet with our team at the event.

Schedule a meeting

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.

Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.